(HOLX) - Hologic, Inc - unbelievable history of exceeding earnings estimates - 10 straight quarters

HOLX has an unbelievable history of exceeding earnings estimates. The company has done so in 10 straight quarters, nine of which have posted double-digit surprises. Four analysts have raised their full-year 2006 projections. Over the past 60 days, 2006 estimates have increased six cents to $1.22 per share. Full Analysis Hologic, Inc. (HOLX), together with its subsidiaries, develops, manufactures, and distributes diagnostic and medical imaging systems for serving the healthcare needs of women. It focuses on mammography and breast care, and osteoporosis assessment. The company’s mammography and breast care products include breast imaging and related products, such as direct ray digital detector; Selenia full field digital mammography system; screen-film mammography system; SecurView, a breast imaging softcopy workstation; computer-aided detection system; stereotactic breast biopsy system, and breast biopsy products for breast biopsy, tissue removal, and biopsy site marking. HOLX turned in an impressive fourth quarter by coming in with earnings per share of 28 cents, four cents higher than the consensus estimate. Revenue almost doubled to $154.1 million from $78.2 million last year. Analysts were only expecting $137 million. For the full year, the company posted net income of $27.4 million, or 56 cents per share, compared with $28.3 million, or 63 cents per share, last year. The company reported adjusted earnings of $52 million, up from $28.3 million. "We are very pleased to report record revenues for the fourth quarter of fiscal 2006, in addition to full year revenue growth of 61% over fiscal 2005," said Jack Cumming, Chairman and CEO. "Our recent acquisitions contributed to the strong top line growth and laid the foundation for another successful year. Management's focus for the coming fiscal year will be to execute our business strategy relative to our core business, deliver anticipated growth from our acquisitions, improve our margins through lean initiatives and continue to invest in innovation." HOLX has an unbelievable history of exceeding earnings estimates. The company has done so in 10 straight quarters, nine of which have posted double-digit surprises. Four analysts have raised their full-year 2006 projections. Over the past 60 days, 2006 estimates have increased six cents to $1.22 per share. The stock is currently trading at 29.7x 2007 estimates of $1.58 per share, in-line with the company's projected long-term growth rate of 29.50%. Content Courtesy: Zacks Investment Research #1 Ranked Stocks Highlight Archive To truly take advantage of the Zacks Rank, you need to first understand how it works. That is why we created the free special report: Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions. | Blog Home| VitalStocks Home